Blog

Explore the latest insights, breakthroughs, and stories shaping our journey towards innovative research and advancements in STXBP1 and Single Gene disorders on Rafa’s Moonshot Blog.

  • Inside Rafa’s Moonshot’s 2025 Progress for STXBP1

    Inside Rafa’s Moonshot’s 2025 Progress for STXBP1

    A year of science, momentum, and real steps toward treatments for STXBP1. 2025 was our busiest and most productive research year yet. Across laboratories in Israel, the UK, Europe, and the US, we pushed forward on multiple therapeutic strategies, expanded our scientific ecosystem, and reached milestones that only a year…

  • A Grant to Prof. Illana Gozes: Developing R292C STXBP1 Mouse Model

    A Grant to Prof. Illana Gozes: Developing R292C STXBP1 Mouse Model

    We are pleased to announce a continuation grant to Prof. Illana Gozes at Tel Aviv University to establish and comprehensively characterize a mouse model harboring the R292C point mutation in STXBP1. This variant is one of the pathogenic heterozygous mutations known to disrupt synaptic vesicle fusion processes and is clinically…

  • STXBP1 Now Has Its Own ICD-10 Code

    STXBP1 Now Has Its Own ICD-10 Code

    A big milestone! 🎉 We are thrilled to share some fantastic news from the STXBP1 community: STXBP1-related disorders will have their very own ICD-10 code as of October 1, 2025. This is not just bureaucratic jargon: it is a meaningful step forward in recognition, diagnosis, research, and care. What Is…

  • Half a Million Dollars for STXBP1 Research

    Half a Million Dollars for STXBP1 Research

    This year marks a significant milestone in our mission to advance research into STXBP1-related disorders. With over $500,000 in combined funding, we’re powering groundbreaking organoid and rat chimera studies that will deepen our understanding of the disorder and accelerate the path toward effective treatments. A Strategic Grant to Advance Brain…

  • Disease Models: The Key to Unlocking Treatments for STXBP1

    Disease Models: The Key to Unlocking Treatments for STXBP1

    Did you know? The tiny C. elegans worm shares 60-80% of its genes with humans, making it an invaluable tool in genetic research. At Rafa’s Moonshot, we’re using these remarkable creatures, among other models, to pave the way for breakthrough treatments for STXBP1 disorders. When it comes to finding a…

  • Mission Possible: Crafting a Plan to Defeat STXBP1

    Mission Possible: Crafting a Plan to Defeat STXBP1

    When Raphael was diagnosed with a mutation in the STXBP1 gene, we knew that finding a cure would not be simple. A logical plan was needed to ensure that all efforts would help us reach our goal of helping Raphael and other kids in similar conditions as quickly as possible. …

  • Introducing Dr. Hila Ben-Moshe, Rafa’s Moonshot Scientific Director

    Introducing Dr. Hila Ben-Moshe, Rafa’s Moonshot Scientific Director

    When we embarked on this journey, we knew that we must think big for such a challenging mission. In the early days of Raphael’s diagnosis, Ella and I prepared our strategic plan and understood two important things:  This led us to search for a scientific director to join and complete…

  • Launching Rafa’s Moonshot

    Launching Rafa’s Moonshot

    Hello all,  We are thrilled to announce the official launch of Rafa’s Moonshot, our research fund dedicated to finding a cure for STXBP1 disorders and related single-gene diseases. Our blog aims to share updates on our ongoing research, highlight new advancements and technologies, and share inspiring stories from pioneers in…

  • Five Key Steps to Kick Off Our Rare Disease Journey

    Five Key Steps to Kick Off Our Rare Disease Journey

    When Raphael was diagnosed with STXBP1, the doctor looked into our eyes and simply said “There is no cure.” With just 600 diagnosed cases worldwide and barely any research available, the news felt devastating and frustrating. Ella and I refused to accept this grim prognosis – instead, we took action.…